These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 24914822
1. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies. Zacharioudakis IM, Ziakas PD, Mylonakis E. Biol Blood Marrow Transplant; 2014 Oct; 20(10):1650-4. PubMed ID: 24914822 [Abstract] [Full Text] [Related]
5. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period. Aldrete SD, Kraft CS, Magee MJ, Chan A, Hutcherson D, Langston AA, Greenwell BI, Burd EM, Friedman-Moraco R. Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501 [Abstract] [Full Text] [Related]
6. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada. Lavallée C, Labbé AC, Talbot JD, Alonso CD, Marr KA, Cohen S, Laverdière M, Dufresne SF. Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498 [Abstract] [Full Text] [Related]
11. Prevalence of Clostridium difficile Infection in the Hematopoietic Transplantation Setting: Update of Systematic Review and Meta-Analysis. Luo Y, Zhang S, Shang H, Cui W, Wang Q, Zhu B. Front Cell Infect Microbiol; 2022 Feb; 12():801475. PubMed ID: 35265530 [Abstract] [Full Text] [Related]
13. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation. Salamonowicz M, Ociepa T, Frączkiewicz J, Szmydki-Baran A, Matysiak M, Czyżewski K, Wysocki M, Gałązka P, Zalas-Więcek P, Irga-Jaworska N, Drożyńska E, Zając-Spychała O, Wachowiak J, Gryniewicz-Kwiatkowska O, Czajńska-Deptuła A, Dembowska-Bagińska B, Chełmecka-Wiktorczyk L, Balwierz W, Bartnik M, Zielezińska K, Urasiński T, Tomaszewska R, Szczepański T, Płonowski M, Krawczuk-Rybak M, Pierlejewski F, Młynarski W, Gamrot-Pyka Z, Woszczyk M, Małas Z, Badowska W, Urbanek-Dądela A, Karolczyk G, Stolpa W, Sobol-Milejska G, Zaucha-Prażmo A, Kowalczyk J, Goździk J, Gorczyńska E, Jermakow K, Król A, Chybicka A, Ussowicz M, Kałwak K, Styczyński J. Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1805-1812. PubMed ID: 29978303 [Abstract] [Full Text] [Related]
14. Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis. Vehreschild MJ, Weitershagen D, Biehl LM, Tacke D, Waldschmidt D, Töx U, Wisplinghoff H, Von Bergwelt-Baildon M, Cornely OA, Vehreschild JJ. Biol Blood Marrow Transplant; 2014 Jun; 20(6):823-8. PubMed ID: 24607558 [Abstract] [Full Text] [Related]
15. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Chopra T, Alangaden GJ, Chandrasekar P. Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1113-9. PubMed ID: 20954878 [Abstract] [Full Text] [Related]
16. Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Mani S, Rybicki L, Jagadeesh D, Mossad SB. Bone Marrow Transplant; 2016 May; 51(5):713-7. PubMed ID: 26726944 [Abstract] [Full Text] [Related]